Mr. Moulder has served as one of our directors since February 2010. He served as Vice Chairman, President and Chief Executive Officer of Abraxis BioScience, Inc. from April 2009 to January 2010. Previously, Mr. Moulder served as Vice Chairman of Eisai Corporation of North America from January 2008 until January 2009, after Eisai acquired MGI PHARMA, Inc., where he had served consecutively as Executive Vice President, President and Chief Operating Officer, and President and Chief Executive Officer from September 1999 to January 2008. Prior to joining MGI PHARMA, from October 1997 to September 1999, Mr. Moulder was Vice President, Business Development and Commercial Affairs and a member of the initial management team at Eligix Inc., a developmental stage biomedical company focused on developing therapies for cancer, infectious disease and auto-immune diseases, located in Boston. Mr. Moulder began his career as a clinical pharmacist, followed by sixteen years of commercial management experience beginning with Marion Laboratories and ultimately advancing through various management positions at successor companies, Marion Merrel Dow and Hoechst Marion Roussel, where he was Product Group Director, Oncology and Anti-infectives. He received his B.S. in Pharmacy from Temple University and an M.B.A. from the University of Chicago.